New manufacturing and control technologies are being explored.
Industry 4.0-the paradigm of connecting physical systems by direct machine-to-machine communications via the Industrial Internet of Things-promises to improve efficiency, and companies across the pharmaceutical industry are embracing “digital transformation.” Merck, for example, seeks to connect “smart factories” for responsive and adaptive manufacturing (1). Pfizer is moving towards “connected manufacturing plants” that make data visible and available on demand (1). Sanofi is employing “digital twins” to simulate their biopharma manufacturing processes, as well as using collaborative robots, augmented reality, and paperless operations (1).
Learn more at CPhI WorldWide 2018, which will feature a Keynote Session Discussion panel on creating an Industry 4.0 Strategy for manufacturing.
